Go Deep
Cue Biopharma, Inc.
Cue Biopharma, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -8,013 | -0.7 | 58.49 | 1.33 | 1,766.02 |
| Oct 2026 | -8,131 | -0.7 | 58.71 | 1.33 | 1,772.92 |
| Oct 2026 | -4,841 | -0.6 | 52.55 | 1.33 | 1,582.69 |
| Oct 2026 | -3,781 | -0.5 | 50.57 | 1.33 | 1,524.65 |
| Oct 2026 | -5,396 | -0.6 | 53.59 | 1.33 | 1,615.67 |
| Oct 2026 | -8,610 | -0.6 | 59.59 | 1.33 | 1,792.33 |
| Oct 2026 | -8,509 | -0.6 | 59.41 | 1.33 | 1,783.04 |
Cue Biopharma, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Cue Biopharma, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Cue Biopharma, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Cue Biopharma, Inc. owed $0.92 for every $1 it owned in Jun 2026, up from $0.28 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.92× | 0.37× | 0.46× | 0.40× | 0.28× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Cue Biopharma, Inc. Cash Flow
Cash flow data isn't available for this company right now.